Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Kite Pharma, Inc. (KITE) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2017 4 DOUMANI ROY (Director) has filed a Form 4 on Kite Pharma, Inc.
Txns: Unknown transaction of 150,620 shares @ $180, valued at $27.1M
Disposed/sold 1,807 shares @ $0
Unknown transaction of 25,065 shares @ $180, valued at $4.5M
Disposed/sold 30,000 options to buy @ $6.89, valued at $206.7k
Disposed/sold 10,000 options to buy @ $59.23, valued at $592.3k
Disposed/sold 7,000 options to buy @ $50.87, valued at $356.1k
Disposed/sold 8,810 options to buy @ $91.21, valued at $803.6k
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2017 4 JENKINSON PAUL L (CFO) has filed a Form 4 on Kite Pharma, Inc.
Txns: Disposed/sold 9,462 shares @ $0
Disposed/sold 3,000 shares @ $180, valued at $540k
Disposed/sold 41,666 options to buy @ $45.04, valued at $1.9M
Disposed/sold 83,334 options to buy @ $45.04, valued at $3.8M
Disposed/sold 24,200 options to buy @ $46.09, valued at $1.1M
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/27/2017 4 Tomasello Shawn (Chief Commercial Officer) has filed a Form 4 on Kite Pharma, Inc.
Txns: Granted 4,500 shares @ $0
Sold 4,203 shares @ $179.6639, valued at $755.1k
09/27/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/27/2017 4 MOORE TIMOTHY L. (EVP, Technical Operations) has filed a Form 4 on Kite Pharma, Inc.
Txns: Sold 7,511 shares @ $83.31, valued at $625.7k
Granted 8,000 shares @ $0
Sold 4,228 shares @ $179.6639, valued at $759.6k
09/27/2017 4 Wiezorek Jeffrey (SVP Clinical Development) has filed a Form 4 on Kite Pharma, Inc.
Txns: Granted 10,000 shares @ $0
Sold 5,283 shares @ $179.6639, valued at $949.2k
09/27/2017 4 Chang David D (EVP, R&D, Chief Medical Off.) has filed a Form 4 on Kite Pharma, Inc.
Txns: Granted 15,000 shares @ $0
Sold 7,927 shares @ $179.6639, valued at $1.4M
09/27/2017 4 JENKINSON PAUL L (CFO) has filed a Form 4 on Kite Pharma, Inc.
Txns: Granted 2,500 shares @ $0
Sold 948 shares @ $179.6639, valued at $170.3k
09/27/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/27/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/14/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/14/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2017 4 MOORE TIMOTHY L. (EVP, Technical Operations) has filed a Form 4 on Kite Pharma, Inc.
Txns: Sold 869 shares @ $110.1, valued at $95.7k
Sold 5,131 shares @ $110.05, valued at $564.7k
Exercised 6,000 options to buy @ $44.91, valued at $269.5k
08/03/2017 4 MOORE TIMOTHY L. (EVP, Technical Operations) has filed a Form 4 on Kite Pharma, Inc.
Txns: Sold 2,477 shares @ $106.85, valued at $264.7k
Sold 5,431 shares @ $107.58, valued at $584.3k
Sold 3,771 shares @ $108.27, valued at $408.3k
Sold 321 shares @ $109.35, valued at $35.1k
Exercised 3,000 options to buy @ $44.91, valued at $134.7k
08/01/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/11/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2017 4 Wiezorek Jeffrey (SVP Clinical Development) has filed a Form 4 on Kite Pharma, Inc.
Txns: Sold 8,799 shares @ $104.26, valued at $917.4k
Sold 1,201 shares @ $104.76, valued at $125.8k
Exercised 10,000 options to buy @ $6.89, valued at $68.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy